Clinical and in vivo confocal microscopy findings in patients receiving tamoxifen citrate

Eye and Contact Lens

Volumn 32, Issue 5, 2006, Pages 228-232

  Muftuoglu, Orkun ^a,b   Uçakhan, Ömür Özlenen ^a   Kanpolat, Ayfer ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GOP   (Turkey)

Author keywords

Cornea verticillium; In vivo confocal microscopy; Tamoxifen citrate

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CELL DENSITY; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA CELL; CORNEA STROMA; CORNEA THICKNESS; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG EYE LEVEL; ENDOTHELIUM CELL; FEMALE; HUMAN; KERATOPATHY; PRIORITY JOURNAL; PUPIL; SCHIRMER TEST; SLIT LAMP; SPECULAR MICROSCOPY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CORNEA; CORNEAL DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MICROSCOPY, CONFOCAL; MIDDLE AGED; TAMOXIFEN;

EID: 33748770931     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icl.0000201396.74294.85     Document Type: Article

References (19)

1. Hollander DA, Aldave AJ. Drug-induced corneal complications. Curr Opin Ophthalmol 2004;15:541-548.
2. Nayfield SG, Gorin MB. Tamoxifen-associated eye disease. J Clin Oncol 1996;14:1018-1026.
3. Gorin MB, Day R, Constantino JP. Long term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 1998;125:493-501.
4. Flach AJ. Clear evidence that long term, low dose tamoxifen treatment can induce ocular toxicity: A prospective study of 63 patients. Surv Ophthalmol 1994;38:392-393.
5. Heier SJ, Dragoo RA, Enzenauer RW, et al. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 1994;117:772-775.
6. Ah-Song R, Sasco AJ. Tamoxifen and ocular toxicity. Cancer Detect Prev 1997;21:522-531.
7. Pavlidis NA, Petris C, Briassoulis E, et al. Clear evidence that long-term, low dose tamoxifen treatment can induce ocular toxicity: A prospective study of 63 patients. Cancer 1992;69:2961-2964.
8. Noureddin BN, Seoud M, Bashshur Z. Ocular toxicity in low-dose tamoxifen: A prospective study. Eye 1999;13:729-733.
9. Parkkari M, Paakkala AM, Salminen L, et al. Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: A randomized follow-up study. Acta Ophthalmol Scand 2003;81:495-499.
10. Cavanagh HD, Petroll WM, Alizadeh H, et al. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 1993;100:1444-1454.
11. Ucakhan OO, Kanpolat A, Yilmaz N, et al. Amiodarone keratopathy: An in vivo confocal microscopy study. Eye Contact Lens 2005;31:148-157.
12. Ucakhan OO, Kanpolat A, Yilmaz N. In vivo confocal microscopy of megalocornea with central mosaic dystrophy. Clin Exp Ophthalmol 2005;33:102-105.
13. Orlando RG, Dangel ME, Schaal SF. Clinical experience and grading of amiodarone keratopathy. Ophthalmology 1984;91:1184-1187.
14. D'Amico DJ, Kenyon KR. Drug-induced lipidoses of the cornea and conjunctiva. Int Ophthalmol 1991;4:67-76.
15. Dua HS, Singh A, Gomes JA, et al. Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye 1996;10:447-450.
16. Gass JD. The iron lines of the superficial cornea: Hudson-Stahli line, Stocker's line and Fleischer's ring. Arch Ophthalmol 1964;71:348-358.
17. Assil KA, Quantock AJ, Barett AM, et al. Corneal iron lines associated with the intrastromal corneal ring. Am J Ophthalmol 1993;116:350-356.
18. Ciancaglini M, Carpineto P, Zuppardi E. In vivo confocal microscopy of patients with amiodarone-induced keratopathy. Cornea 2001;20:368-373.
19. Slowik C, Somodi S, von Gruben C, et al. Detection of morphological corneal changes caused by chloroquine therapy using confocal in vivo microscopy. Ophthalmologe 1997;94:147-151.